On the 6th August Paul Pipkin (Pip) will be embarking on a 211 mile walk for MS Research. He will start in Whitehaven on the west coast of England and end up at St Mary's lighthouse on the east coast going via the historic Hadrian’s Wall.
Since Pip’s wife Deb was diagnosed with Multiple Sclerosis (MS) 12 years ago they have both become dedicated fundraisers for MS charities and have supported MS Research since 2015 for which we are extremely grateful.
Our chair Dr Rosie Jones shares her thoughts on ‘Treatment Algorithms for Multiple Sclerosis Disease-Modifying Therapies’ (full document here)- an important document recently released by NHS England which updates the current guidance for medical professionals on drugs and other therapeutic approaches in early relapse/remitting MS.
We have an opportunity for you take part in a short online survey on perspectives towards using cannabis-based medicines as treatment for Multiple Sclerosis in the UK.
The research conducted is by a King’s College London student who aims to investigate views towards the availability and accessibility of cannabis-based medicines such as Sativex in the UK. This is a voluntary questionnaire particularly aimed at family members and carers of those affected by MS.
We asked four members of our board for their thoughts on why they think being a Trustee for MS Research is important:
He writes: “…all disease-modifying treatments have the possibility of side effects, and some are more serious than others. We who use the treatments should always be doing so with our eyes wide open and fully informed of the risks.”
